Company / Net Income
KYNTRA BIO, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$47.6M
FY2025
5-year range
-$290.0M / -$47.6M
FY2021-FY2025
Trend
+83.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$290M in FY2023 to -$48M in FY2025.
Based on SEC 10-K filings.
-$48M in FY2025.
Improved from -$290M to -$48M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 83.3% year-over-year.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$47.6M | +83.3% |
| FY2024 | -$284.2M | +2.0% |
| FY2023 | -$290.0M | -53.2% |
| FY2022 | -$189.3M | -145.9% |
| FY2021 | -$77.0M | +10.9% |
| FY2020 | -$86.4M | +28.5% |
| FY2019 | -$120.9M | -108.2% |
| FY2018 | -$58.1M | +32.3% |
| FY2017 | -$85.8M | -44.2% |
| FY2016 | -$59.5M | -298.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026